Covid-19 roundup: Pfiz­er tees up 500M vac­cine dos­es for do­na­tion in ex­pand­ed US pact; Ear­ly remde­sivir helps stave off hos­pi­tal­iza­tions — study

Pfiz­er and BioN­Tech will sell 500 mil­lion dos­es of their Comir­naty Covid-19 vac­cine to the US at cost as part of an ex­pand­ed agree­ment to dri­ve do­na­tions to low- and mid­dle-in­come na­tions, the drug­mak­er said Wednes­day.

The ex­pand­ed pact dou­bles Pfiz­er/BioN­Tech’s com­mit­ment to the US ef­fort, which will ship do­na­tions to CO­V­AX, a glob­al clear­ing­house for up to 92 tar­get na­tions, as well as the 55 mem­ber states of the African Union, Pfiz­er said. De­liv­er­ies start­ed in Au­gust and are ex­pect­ed to run through Sep­tem­ber 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER